This company's SP journey is remarkedly similar to RFN - started off way too high, corrected to $0.01, and now after a few years is finally gaining potentially real traction
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025